Lineage Cell Therapeutics
LCTX
#7579
Rank
โ‚ฌ0.33 B
Marketcap
1,46ย โ‚ฌ
Share price
-1.72%
Change (1 day)
151.09%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -โ‚ฌ18.35 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ10.81 Million. In 2024 the company made an earning of -โ‚ฌ18.31 Million, an increase over its 2023 earnings that were of -โ‚ฌ21.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ18.35 Million0.16%
2024 -โ‚ฌ18.31 Million-13.16%
2023 -โ‚ฌ21.09 Million9.83%
2022 -โ‚ฌ19.2 Million-54.24%
2021 -โ‚ฌ41.96 Million86.07%
2020 -โ‚ฌ22.55 Million-31.97%
2019 -โ‚ฌ33.15 Million-5.42%
2018 -โ‚ฌ35.05 Million1.1%
2017 -โ‚ฌ34.66 Million-31.06%
2016 -โ‚ฌ50.28 Million-10.38%
2015 -โ‚ฌ56.1 Million29.69%
2014 -โ‚ฌ43.26 Million31.68%
2013 -โ‚ฌ32.85 Million
2011 -โ‚ฌ15.95 Million89.78%
2010 -โ‚ฌ8.4 Million206.06%
2009 -โ‚ฌ2.75 Million-0.58%
2008 -โ‚ฌ2.77 Million164.89%
2007 -โ‚ฌ1.05 Million-30.22%
2006 -โ‚ฌ1.5 Million
2002 -โ‚ฌ1.74 Million-41.04%
2001 -โ‚ฌ2.95 Million-32.04%
2000 -โ‚ฌ4.33 Million-11.85%
1999 -โ‚ฌ4.92 Million
1997 -โ‚ฌ3.16 Million12.12%
1996 -โ‚ฌ2.82 Million106.25%
1995 -โ‚ฌ1.37 Million-11.11%
1994 -โ‚ฌ1.54 Million50%
1993 -โ‚ฌ1.03 Million20%
1992 -โ‚ฌ0.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.13 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA